Psoas Abscess Due to
Mycobacterium avium
abscess
chronic lymphocytic leukemia
ibrutinib
immunosuppression
infection
non-tuberculous mycobacteria
obinutuzumab
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
07 Feb 2019
07 Feb 2019
Historique:
received:
29
01
2019
revised:
05
02
2019
accepted:
05
02
2019
entrez:
10
2
2019
pubmed:
10
2
2019
medline:
10
2
2019
Statut:
epublish
Résumé
Infections may constitute a serious complication in patients with chronic lymphocytic leukemia (CLL). New treatment agents including obinutuzumab and ibrutinib have improved the progression-free survival in CLL, and data suggest a similar overall infection risk and a limited risk of opportunistic infections when compared to standard chemo-immunotherapy. Nevertheless, cases of opportunistic infections including non-tuberculous mycobacterial (NTM) in CLL patients have recently been published. We present a case of a 74-year old man with extensive prior CLL treatment history, including most recently obinutuzumab. He developed an abscess of the psoas muscle and inguinal lymphadenopathy. An inguinal node biopsy specimen showed infection with
Identifiants
pubmed: 30736487
pii: jcm8020216
doi: 10.3390/jcm8020216
pmc: PMC6406768
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Intern Med. 2000 Oct;248(4):343-8
pubmed: 11086646
J Infect. 2002 Apr;44(3):201-3
pubmed: 12099753
Br J Haematol. 2003 Aug;122(4):600-6
pubmed: 12899715
Br J Haematol. 2004 Oct;127(2):126
pubmed: 15461617
J Clin Pathol. 2005 Aug;58(8):815-9
pubmed: 16049282
Cancer. 2006 Sep 1;107(5):1023-33
pubmed: 16862572
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416
pubmed: 17277290
Haematologica. 2007 Jan;92(1):e5-6
pubmed: 17405741
J Infect. 2008 Feb;56(2):151-4
pubmed: 18199481
Pharmacotherapy. 2008 Feb;28(2):281-4
pubmed: 18225973
Clin Infect Dis. 2008 Apr 1;46(7):e69-71
pubmed: 18444808
Emerg Infect Dis. 2009 Oct;15(10):1556-61
pubmed: 19861045
Am J Respir Crit Care Med. 2010 Oct 1;182(7):977-82
pubmed: 20508209
Br J Haematol. 2011 Apr;153(2):148
pubmed: 21401570
Br J Haematol. 2014 Jan;164(1):1
pubmed: 24106813
N Engl J Med. 2014 Mar 20;370(12):1101-10
pubmed: 24401022
J Thorac Dis. 2014 Mar;6(3):210-20
pubmed: 24624285
Leuk Lymphoma. 2015 Feb;56(2):311-4
pubmed: 24738974
N Engl J Med. 2015 Dec 17;373(25):2425-37
pubmed: 26639149
Thorax. 2017 Nov;72(Suppl 2):ii1-ii64
pubmed: 29054853
Lancet. 2018 Apr 14;391(10129):1524-1537
pubmed: 29477250
Blood Rev. 2018 Sep;32(5):387-399
pubmed: 29571669
Blood Rev. 2018 Nov;32(6):499-507
pubmed: 29709246
Open Forum Infect Dis. 2018 Jul 18;5(7):ofy168
pubmed: 30090839
N Engl J Med. 2018 Dec 27;379(26):2517-2528
pubmed: 30501481